22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol
    6.
    发明授权
    22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol 失效
    22-差向异构体-1,25-二羟基-16,22,23-三烯 - 胆钙化甾醇

    公开(公告)号:US5840718A

    公开(公告)日:1998-11-24

    申请号:US811809

    申请日:1997-03-06

    IPC分类号: C07F7/18 A61K31/59

    CPC分类号: C07F7/1844 C07F7/1856

    摘要: The invention relates to a compound of the formula ##STR1## wherein R is hydroxy and R.sup.1 is H.sub.2 or .dbd.CH.sub.2 or R is hydrogen or fluoro and R.sup.1 is .dbd.CH.sub.2 and (b) an inert carrier. Compounds of formula I are useful as agents for the treatment of hyperproliferative skin diseases, such as psoriasis, neoplastic diseases, such as leukemia, and sebaceous gland diseases, such as acne and sebhorreic dermatitis.

    摘要翻译: 本发明涉及式Ⅰ化合物,其中R为羟基,R 1为H 2或= CH 2或R为氢或氟并且R 1为= CH 2和(b)惰性载体。 式I化合物可用作治疗过度增生性皮肤病的药剂,例如牛皮癣,肿瘤性疾病如白血病和皮脂腺疾病如痤疮和皮脂腺性皮炎。